Abbott has revamped the digital health app used alongside its neurostimulation devices for chronic pain, making it easier for doctors to track how well patients are managing the treatment.<
GSK’s Arexvy has become the first vaccine for respiratory syncytial virus (RSV) to be approved in the EU, getting the nod from the European Commission for use in older adu
Health systems globally have reached a critical inflexion point, where ageing populations and tightening budgets mean we can no longer continue to purely treat late-stage symptomatic diseas
